Publications by authors named "Mathias Jenal"

Claim this Profile
T
The Clinical Effectiveness of Denosumab (Prolia®) for the Treatment of Osteoporosis in Postmenopausal Women, Compared to Bisphosphonates, Selective Estrogen Receptor Modulators (SERM), and Placebo: A Systematic Review and Network Meta-Analysis.
Magdalena Ruth Moshi, Konstance Nicolopoulos, Danielle Stringer, Ning Ma, Mathias Jenal

Calcif Tissue Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical effectiveness of denosumab (Prolia®) in patients with hormone-sensitive cancer receiving endocrine therapy, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysis.
Konstance Nicolopoulos, Magdalena Ruth Moshi, Danielle Stringer, Ning Ma, Mathias Jenal

Arch Osteoporos· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.
E Robert McDonald, Antoine de Weck, Michael R Schlabach, Eric Billy, Konstantinos J Mavrakis, Mathias Jenal

Cell· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E2F mediates enhanced alternative polyadenylation in proliferation.
Ran Elkon, Jarno Drost, Gijs van Haaften, Mathias Jenal, Mariette Schrier

Genome Biol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells.
Jasmin Batliner, Emanuel Buehrer, Elena A Federzoni, Mathias Jenal, Andreas Tobler

Br J Haematol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites.
Mathias Jenal, Ran Elkon, Fabricio Loayza-Puch, Gijs van Haaften, Uwe Kühn

Cell· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?
Mathias Jenal, Christian Britschgi, Martin F Fey, Mario P Tschan

Swiss Med Wkly· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation.
Jasmin Batliner, Maria Michela Mancarelli, Mathias Jenal, Venkateshwar A Reddy, Martin F Fey

Mol Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1).
Capucine Van Rechem, Brian R Rood, Majid Touka, Sébastien Pinte, Mathias Jenal

J Biol Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Mathias Jenal, Emmanuelle Trinh, Christian Britschgi, Adrian Britschgi, Vincent Roh

Mol Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation.
Christian Britschgi, Mathias Jenal, Mattia Rizzi, Beatrice U Mueller, Bruce E Torbett

Br J Haematol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis